These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9041182

  • 21. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A, Diccianni MB, Yu JC, Nobori T, Link MP, Pullen J, Yu AL.
    Cancer Res; 1997 Mar 01; 57(5):832-6. PubMed ID: 9041181
    [Abstract] [Full Text] [Related]

  • 22. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T, Mizushima Y, Kashii T, Kobayashi M.
    Anticancer Res; 1998 Mar 01; 18(3A):1537-42. PubMed ID: 9673367
    [Abstract] [Full Text] [Related]

  • 23. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 24. Methylation and messenger RNA expression of p15INK4b but not p16INK4a are independent risk factors for ovarian cancer.
    Liu Z, Wang LE, Wang L, Lu KH, Mills GB, Bondy ML, Wei Q.
    Clin Cancer Res; 2005 Jul 01; 11(13):4968-76. PubMed ID: 16000597
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y, Hayashi H, Kawai K, Kurakane T, Saitoh Y, Kitamura S, Sengoku K, Ishikawa M.
    Exp Cell Res; 1997 Jun 15; 233(2):233-9. PubMed ID: 9194486
    [Abstract] [Full Text] [Related]

  • 26. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG.
    Leukemia; 1998 Jun 15; 12(6):845-59. PubMed ID: 9639410
    [Abstract] [Full Text] [Related]

  • 27. p16INK4A and p15INK4B gene deletions in primary leukemias.
    Haidar MA, Cao XB, Manshouri T, Chan LL, Glassman A, Kantarjian HM, Keating MJ, Beran MS, Albitar M.
    Blood; 1995 Jul 01; 86(1):311-5. PubMed ID: 7795238
    [Abstract] [Full Text] [Related]

  • 28. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia.
    Tsellou E, Troungos C, Moschovi M, Athanasiadou-Piperopoulou F, Polychronopoulou S, Kosmidis H, Kalmanti M, Hatzakis A, Dessypris N, Kalofoutis A, Petridou E.
    Eur J Cancer; 2005 Mar 01; 41(4):584-9. PubMed ID: 15737564
    [Abstract] [Full Text] [Related]

  • 29. Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia.
    Aggerholm A, Guldberg P, Hokland M, Hokland P.
    Cancer Res; 1999 Jan 15; 59(2):436-41. PubMed ID: 9927059
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K, Oda Y, Saito T, Yamamoto H, Tamiya S, Takahira T, Miyajima K, Iwamoto Y, Tsuneyoshi M.
    J Pathol; 2003 Nov 15; 201(3):487-95. PubMed ID: 14595762
    [Abstract] [Full Text] [Related]

  • 31. [Analysis of cyclin dependent kinase inhibitors, p16INK4a and p15INK4b gene, in acute lymphoblastic leukemias].
    Kaname M, Watanabe H, Fukuchi K, Akagi Y, Takagi Y, Tomoyasu S, Tsuruoka N, Gomi K.
    Rinsho Byori; 1996 Aug 15; 44(8):771-7. PubMed ID: 8816064
    [Abstract] [Full Text] [Related]

  • 32. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
    Papageorgiou SG, Lambropoulos S, Pappa V, Economopoulou C, Kontsioti F, Papageorgiou E, Tsirigotis P, Dervenoulas J, Economopoulos T.
    Am J Hematol; 2007 Sep 15; 82(9):824-5. PubMed ID: 17546638
    [Abstract] [Full Text] [Related]

  • 33. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
    Melki JR, Vincent PC, Clark SJ.
    Cancer Res; 1999 Aug 01; 59(15):3730-40. PubMed ID: 10446989
    [Abstract] [Full Text] [Related]

  • 34. Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection.
    Kim JW, Namkoong SE, Ryu SW, Kim HS, Shin JW, Lee JM, Kim DH, Kim IK.
    Gynecol Oncol; 1998 Jul 01; 70(1):75-9. PubMed ID: 9698478
    [Abstract] [Full Text] [Related]

  • 35. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
    Perrone F, Tamborini E, Dagrada GP, Colombo F, Bonadiman L, Albertini V, Lagonigro MS, Gabanti E, Caramuta S, Greco A, Torre GD, Gronchi A, Pierotti MA, Pilotti S.
    Cancer; 2005 Jul 01; 104(1):159-69. PubMed ID: 15929122
    [Abstract] [Full Text] [Related]

  • 36. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
    Kawamata N, Inagaki N, Mizumura S, Sugimoto KJ, Sakajiri S, Ohyanagi-Hara M, Oshimi K.
    Eur J Haematol; 2005 May 01; 74(5):424-9. PubMed ID: 15813917
    [Abstract] [Full Text] [Related]

  • 37. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging.
    Zindy F, Quelle DE, Roussel MF, Sherr CJ.
    Oncogene; 1997 Jul 10; 15(2):203-11. PubMed ID: 9244355
    [Abstract] [Full Text] [Related]

  • 38. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
    Delmer A, Tang R, Senamaud-Beaufort C, Paterlini P, Brechot C, Zittoun R.
    Leukemia; 1995 Jul 10; 9(7):1240-5. PubMed ID: 7630199
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.